newsfilter
← Latest News
Business Wire·

PhaseBio Reports First Quarter 2020 Financial Results and Recent Business Highlights

MALVERN, Pa & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today reported financial results from the first quarter ending March 31, 2020 and provided an update on corporate activities.